David A. Asch

faculty photo
John Morgan Professor
Department: Medicine

Contact information
14-171 PCAM South Tower
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-746-2705
A.B. (Philosophy)
Harvard University, 1980.
M.D. (Medicine)
Cornell University, 1984.
M.B.A. (Decision Sciences and Health Care Management)
The Wharton School, 1989.
American Board of Internal Medicine , 1987.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Bioethics Expertise

Behavioral Economics, Health Policy, Medical Education

Dr. Asch is John Morgan Professor of Medicine at the Perelman School of Medicine and Professor of Health Care Management and Operations, Information and Decisions at the Wharton School. He is Executive Director of the Penn Medicine Center for Health Care Innovation

Dr. Asch is interested in the moral and cognitive determinants of the decisions made by clinicians and patients. This area of research combines elements of quantitative medical decision making with moral and psychological theory. He has special interests in decisions that involve diagnostic tests (including genetic screening), end of life concerns, and tradeoffs between the interests of individuals and groups.

Selected Publications

Kohn Rachel, Madden Vanessa, Kahn Jeremy M, Asch David A, Barnato Amber E, Halpern Scott D, Kerlin Meeta Prasad: Diffusion of Evidence-based Intensive Care Unit Organizational Practices. A State-Wide Analysis. Annals of the American Thoracic Society 14(2): 254-261, Feb 2017.

Asch DA, Rosin R: Engineering Social Incentives for Health. N Engl J Med 375(26): 2511-3, Dec 2016.

Sinnenberg L, DiSilvestro CL, Mancheno C, Dailey K, Tufts C, Buttenheim AM, Barg F, Ungar L, Schwartz H, Brown D, Asch DA, Merchant RM: Twitter as a Potential Data Source for Cardiovascular Disease Research. JAMA Cardiology 1(9): 1032-1036, Dec 2016.

Liu T, Asch DA, Volpp KG, Zhu J, Wang W, Troxel AB, Adejare A, Finnerty DD, Hoffer K, Shea JA: Physician attitudes toward participating in a financial incentive program for LDL reduction are associated with patient outcomes. Healthcare (Amsterdam, Netherlands) 5(3): 119-124, Dec 2016.

Gopalan A, Paramanund J, Shaw PA, Patel D, Friedman J, Brophy C, Buttenheim AM, Troxel AB, Asch DA, Volpp KG: Randomised controlled trial of alternative messages to increase enrolment in a healthy food programme among individuals with diabetes. BMJ Open 6(11): e012009, Nov 2016.

Volpp KG, Asch DA: Make the Healthy Choice the Easy Choice: Using Behavioral Economics to Advance a Culture of Health. QJM : Monthly Journal of the Association of Physicians Nov 2016.

Mehta SJ, Troxel AB, Marcus N, Jameson C, Taylor D, Asch DA, Volpp KG: Participation Rates With Opt-out Enrollment in a Remote Monitoring Intervention for Patients With Myocardial Infarction. JAMA Cardiology 1(7): 847-848, Oct 2016.

Troxel AB, Asch DA, Volpp KG: Statistical issues in pragmatic trials of behavioral economic interventions. Clinical Trials (London, England) 13(5): 478-83, Oct 2016.

Patel MS, Asch DA, Volpp KG: Framing Financial Incentives to Increase Physical Activity Among Overweight and Obese Adults. Annals of Internal Medicine 165(8): 600, Oct 2016.

Halpern SD, French B, Small DS, Saulsgiver K, Harhay MO, Audrain-McGovern J, Loewenstein G, Asch DA, Volpp KG: Heterogeneity in the Effects of Reward- and Deposit-based Financial Incentives on Smoking Cessation. Am J Resp and Crit Care Med 194(8): 981-988, Oct 2016.

back to top
Last updated: 03/01/2018
The Trustees of the University of Pennsylvania